Cargando…
Targeted disruption of glycogen synthase kinase-3β in cardiomyocytes attenuates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice
Type 1 diabetic Akita mice develop severe cardiac parasympathetic dysfunction that we have previously demonstrated is due at least in part to an abnormality in the response of the end organ to parasympathetic stimulation. Specifically, we had shown that hypoinsulinemia in the diabetic heart results...
Autores principales: | Zhang, Yali, Welzig, Charles M., Haburcak, Marian, Wang, Bo, Aronovitz, Mark, Blanton, Robert M., Park, Ho-Jin, Force, Thomas, Noujaim, Sami, Galper, Jonas B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461277/ https://www.ncbi.nlm.nih.gov/pubmed/30978208 http://dx.doi.org/10.1371/journal.pone.0215213 |
Ejemplares similares
-
Glycogen Synthase Kinase-3β Inhibition Ameliorates Cardiac Parasympathetic Dysfunction in Type 1 Diabetic Akita Mice
por: Zhang, Yali, et al.
Publicado: (2014) -
Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
por: Haq, Syed, et al.
Publicado: (2000) -
Increasing hepatic glycogen moderates the diabetic phenotype in insulin-deficient Akita mice
por: López-Soldado, Iliana, et al.
Publicado: (2021) -
Inhibition of Glycogen Synthase Kinase 3β Activity in the Basolateral Amygdala Disrupts Reconsolidation and Attenuates Heroin Relapse
por: Xie, Yuanyang, et al.
Publicado: (2022) -
Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β
por: Wu, Wei, et al.
Publicado: (2019)